相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Relapse of Hodgkin's lymphoma (HL) after autologous stem cell transplantation (ASCT): Prognostic factors in 462 patients registered in the database of the EBMT.
C. Martinez et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
A Phase I Weekly Dosing Study of Brentuximab Vedotin in Patients with Relapsed/Refractory CD30-Positive Hematologic Malignancies
Michelle A. Fanale et al.
CLINICAL CANCER RESEARCH (2012)
Hodgkin lymphoma: 2011 update on diagnosis, risk-stratification, and management
Stephen M. Ansell
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma)
Claire E. Dearden et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
CD30: an important new target in hematologic malignancies
Yehuda E. Deutsch et al.
LEUKEMIA & LYMPHOMA (2011)
Intracellular Activation of SGN-35, a Potent Anti-CD30 Antibody-Drug Conjugate
Nicole M. Okeley et al.
CLINICAL CANCER RESEARCH (2010)
Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas.
Anas Younes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Anti-CD30 Antibodies for Hodgkin Lymphoma
Kelley V. Foyil et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2010)
ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified:: report from the International Peripheral T-Cell Lymphoma Project
Kerry J. Savage et al.
BLOOD (2008)
Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma
Navneet S. Majhail et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma
Tarun Kewalramani et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse
A Sureda et al.
ANNALS OF ONCOLOGY (2005)
分享论文
